Annual FCF
-$46.54 M
+$6.21 M+11.77%
31 December 2023
Summary:
Milestone Pharmaceuticals annual free cash flow is currently -$46.54 million, with the most recent change of +$6.21 million (+11.77%) on 31 December 2023. During the last 3 years, it has risen by +$4.20 million (+8.27%). MIST annual FCF is now -475.37% below its all-time high of -$8.09 million, reached on 31 December 2017.MIST Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$7.02 M
-$962.00 K-15.87%
30 September 2024
Summary:
Milestone Pharmaceuticals quarterly free cash flow is currently -$7.02 million, with the most recent change of -$962.00 thousand (-15.87%) on 30 September 2024. Over the past year, it has increased by +$5.16 million (+42.34%). MIST quarterly FCF is now -791.82% below its all-time high of $1.01 million, reached on 30 June 2021.MIST Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$31.84 M
+$5.16 M+13.94%
30 September 2024
Summary:
Milestone Pharmaceuticals TTM free cash flow is currently -$31.84 million, with the most recent change of +$5.16 million (+13.94%) on 30 September 2024. Over the past year, it has increased by +$17.84 million (+35.91%). MIST TTM FCF is now -573.50% below its all-time high of -$4.73 million, reached on 31 March 2018.MIST TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MIST Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +11.8% | +42.3% | +35.9% |
| 3 y3 years | +8.3% | +25.2% | -7.6% |
| 5 y5 years | -121.1% | +18.3% | +24.5% |
MIST Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -40.1% | +11.8% | -15.9% | +50.4% | -7.6% | +39.6% |
| 5 y | 5 years | -121.1% | +11.8% | -791.8% | +61.2% | -15.6% | +46.9% |
| alltime | all time | -475.4% | +11.8% | -791.8% | +61.2% | -573.5% | +46.9% |
Milestone Pharmaceuticals Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$7.02 M(+15.9%) | -$31.84 M(-13.9%) |
| June 2024 | - | -$6.06 M(-32.2%) | -$37.00 M(-10.9%) |
| Mar 2024 | - | -$8.93 M(-9.1%) | -$41.53 M(-10.7%) |
| Dec 2023 | -$46.54 M(-11.8%) | -$9.83 M(-19.3%) | -$46.54 M(-6.3%) |
| Sept 2023 | - | -$12.18 M(+14.9%) | -$49.68 M(+1.0%) |
| June 2023 | - | -$10.60 M(-24.0%) | -$49.18 M(-6.7%) |
| Mar 2023 | - | -$13.94 M(+7.4%) | -$52.73 M(-0.0%) |
| Dec 2022 | -$52.74 M(+58.7%) | -$12.97 M(+11.1%) | -$52.74 M(+1.1%) |
| Sept 2022 | - | -$11.68 M(-17.4%) | -$52.15 M(+4.6%) |
| June 2022 | - | -$14.14 M(+1.4%) | -$49.86 M(+43.7%) |
| Mar 2022 | - | -$13.95 M(+12.7%) | -$34.70 M(+4.5%) |
| Dec 2021 | -$33.22 M | -$12.38 M(+31.8%) | -$33.22 M(+12.2%) |
| Sept 2021 | - | -$9.39 M(-1025.3%) | -$29.60 M(+7.5%) |
| June 2021 | - | $1.01 M(-108.1%) | -$27.55 M(-39.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$12.47 M(+42.4%) | -$45.12 M(-11.1%) |
| Dec 2020 | -$50.73 M(-1.6%) | -$8.76 M(+19.4%) | -$50.73 M(-13.5%) |
| Sept 2020 | - | -$7.33 M(-55.7%) | -$58.68 M(-2.1%) |
| June 2020 | - | -$16.56 M(-8.4%) | -$59.94 M(+9.2%) |
| Mar 2020 | - | -$18.08 M(+8.2%) | -$54.91 M(+6.5%) |
| Dec 2019 | -$51.56 M(+145.0%) | -$16.70 M(+94.4%) | -$51.56 M(+22.3%) |
| Sept 2019 | - | -$8.59 M(-25.5%) | -$42.17 M(+7.7%) |
| June 2019 | - | -$11.54 M(-21.7%) | -$39.17 M(+26.1%) |
| Mar 2019 | - | -$14.73 M(+101.5%) | -$31.06 M(+47.5%) |
| Dec 2018 | -$21.05 M(+160.3%) | -$7.31 M(+30.8%) | -$21.05 M(+53.2%) |
| Sept 2018 | - | -$5.59 M(+63.4%) | -$13.74 M(+68.6%) |
| June 2018 | - | -$3.42 M(-27.6%) | -$8.15 M(+72.4%) |
| Mar 2018 | - | -$4.73 M | -$4.73 M |
| Dec 2017 | -$8.09 M | - | - |
FAQ
- What is Milestone Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for Milestone Pharmaceuticals?
- What is Milestone Pharmaceuticals annual FCF year-on-year change?
- What is Milestone Pharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for Milestone Pharmaceuticals?
- What is Milestone Pharmaceuticals quarterly FCF year-on-year change?
- What is Milestone Pharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for Milestone Pharmaceuticals?
- What is Milestone Pharmaceuticals TTM FCF year-on-year change?
What is Milestone Pharmaceuticals annual free cash flow?
The current annual FCF of MIST is -$46.54 M
What is the all time high annual FCF for Milestone Pharmaceuticals?
Milestone Pharmaceuticals all-time high annual free cash flow is -$8.09 M
What is Milestone Pharmaceuticals annual FCF year-on-year change?
Over the past year, MIST annual free cash flow has changed by +$6.21 M (+11.77%)
What is Milestone Pharmaceuticals quarterly free cash flow?
The current quarterly FCF of MIST is -$7.02 M
What is the all time high quarterly FCF for Milestone Pharmaceuticals?
Milestone Pharmaceuticals all-time high quarterly free cash flow is $1.01 M
What is Milestone Pharmaceuticals quarterly FCF year-on-year change?
Over the past year, MIST quarterly free cash flow has changed by +$5.16 M (+42.34%)
What is Milestone Pharmaceuticals TTM free cash flow?
The current TTM FCF of MIST is -$31.84 M
What is the all time high TTM FCF for Milestone Pharmaceuticals?
Milestone Pharmaceuticals all-time high TTM free cash flow is -$4.73 M
What is Milestone Pharmaceuticals TTM FCF year-on-year change?
Over the past year, MIST TTM free cash flow has changed by +$17.84 M (+35.91%)